All right. Good morning, everyone, and welcome to Masimo's 2025 Investor Day. I'm Matt Brinckman. I recently joined Masimo as Senior Vice President of FP&A and Investor Relations. I've been working ...

Masimo (NASDAQ: MASI) today hosted its 2025 Investor Day at the Company's headquarters. At the event, Masimo's management team provided an update on the Company's long-term strategy, including the ...

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today hosted its 2025 Investor Day at the Company’s headquarters. At the event, Masimo’s management team provided an update on the Company’s long ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in 1993 in Alexandria, VA., by brothers David and Tom ...

Apple has suffered a major defeat in its long-term legal dispute with the medtech firm Masimo and has been ordered to pay $634 million in damages. As the Daily Journal reports, a federal jury agreed ...

A federal jury finds Apple infringed Masimo’s pulse oximetry patent, while the ITC has opened a new proceeding to review Apple's redesigned smartwatch.

Amid its multifront legal battle with Apple over its smartwatch’s blood oxygen sensors, Masimo has claimed new ground—including a significant patent infringement verdict in federal court, plus the ...

What just happened? Apple has been dealt a blow in its long-running patent battle against Masimo after a court ordered Cupertino to pay the health tech firm $634 million. The decision came on the same ...